SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report
Background Seizure-related 6 homolog-like 2 (SEZ6L2) antibody-associated cerebellar ataxia is a rare autoimmune disorder with very limited cases reported in the literature. Responses to conventional immunotherapy are variable. Case presentation We present the case of a patient initially misdiagnosed with alcohol-related brain damage (ARBD) and type 2 diabetes-associated peripheral neuropathy. Following the detection of anti-SEZ6L2 antibodies in both serum and cerebrospinal fluid, the diagnosis was revised to SEZ6L2 antibody-associated cerebellar ataxia. The patient exhibited clinical improvement following combination therapy with double filtration plasmapheresis (DFPP) and glucocorticoids. Conclusion This case highlights the diagnostic challenges of SEZ6L2 autoimmunity, which can mimic toxic or metabolic encephalopathies. Clinical improvement following combined DFPP and glucocorticoid treatment supports a potential therapeutic role for this approach but cannot prove antibody pathogenicity or the independent efficacy of DFPP.
Authors
- Bin Liu (ORCID: https://orcid.org/0000-0003-0713-4346)
- Yuhong Ma (ORCID: https://orcid.org/0009-0008-3883-9211)
- Yuhui Wang
- Tiantian Jiang
- Chunping Zhu
Institutions
- Punan Hospital (CN)
- Chinese People's Liberation Army (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fimmu.2026.1869743
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00